
APDN P/E Ratio
P/E Ratio as of Jul 3, 2025: -0.01
Average-0.0100
Median-0.0100
Minimum-0.0100
Maximum-0.0100
-0.01
Past Month0.00 (0.00%)
The P/E ratio for APDN is -0.01 as of Jul 3, 2025. This represents a decrease of -75.00% compared to its 12-month average P/E ratio of -0.04. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Applied DNA Sciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Applied DNA Sciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Applied DNA Sciences to industry peers.
Applied DNA Sciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Applied DNA Sciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Applied DNA Sciences to industry peers.
APDN P/E Ratio Insights
See Applied DNA Sciences’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in APDN
Order type
Buy in
Order amount
Est. shares
0 shares
APDN P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jul 1, 2025 | $4.56 | -0.01 |
Jun 2, 2025 | $5.83 | -0.01 |
May 1, 2025 | $13.65 | -0.03 |
Apr 1, 2025 | $25.20 | -0.05 |
Mar 3, 2025 | $104.10 | -0.02 |
Feb 3, 2025 | $127.65 | -0.03 |
Jan 2, 2025 | $185.25 | -0.04 |
APDN End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.01 | -75.00% |
2024 | -0.04 | -95.06% |
2023 | -0.81 | -49.38% |
2022 | -1.60 | -24.17% |
2021 | -2.11 | +31.88% |
2020 | -1.60 | — |
FAQs About Applied DNA Sciences (APDN) P/E ratio
The latest P/E ratio of APDN is -0.01, as of Jul 3, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Applied DNA Sciences’s last 12-month average P/E ratio is -0.04, compared to its current P/E ratio of -0.01. This reflects a decrease of -75.00%.
Applied DNA Sciences’s current P/E ratio of -0.01 is lower than its last 12-month average P/E of -0.04. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Applied DNA Sciences’s average P/E ratio over the last 3 years is -1.03. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Applied DNA Sciences’s average P/E ratio over the last 5 years is -1.45. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.